Application of Dendrimers for Treating Parasitic Diseases
Open Access
- 5 March 2021
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (3), 343
- https://doi.org/10.3390/pharmaceutics13030343
Abstract
Despite advances in medical knowledge, parasitic diseases remain a significant global health burden and their pharmacological treatment is often hampered by drug toxicity. Therefore, drug delivery systems may provide useful advantages when used in combination with conventional therapeutic compounds. Dendrimers are three-dimensional polymeric structures, characterized by a central core, branches and terminal functional groups. These nanostructures are known for their defined structure, great water solubility, biocompatibility and high encapsulation ability against a wide range of molecules. Furthermore, the high ratio between terminal groups and molecular volume render them a hopeful vector for drug delivery. These nanostructures offer several advantages compared to conventional drugs for the treatment of parasitic infection. Dendrimers deliver drugs to target sites with reduced dosage, solving side effects that occur with accepted marketed drugs. In recent years, extensive progress has been made towards the use of dendrimers for therapeutic, prophylactic and diagnostic purposes for the management of parasitic infections. The present review highlights the potential of several dendrimers in the management of parasitic diseases.This publication has 199 references indexed in Scilit:
- Molecular target validation, antimicrobial delivery, and potential treatment of Toxoplasma gondii infectionsProceedings of the National Academy of Sciences of the United States of America, 2012
- Leishmaniasis Worldwide and Global Estimates of Its IncidencePLOS ONE, 2012
- Preventing and detecting malaria infectionsThe Nurse Practitioner, 2011
- Malaria gametocytogenesisMolecular and Biochemical Parasitology, 2010
- Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteasesProceedings of the National Academy of Sciences of the United States of America, 2010
- Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA deliveryJournal of Controlled Release, 2009
- MalariaTransfusion Medicine and Hemotherapy, 2009
- Survival of Acanthamoeba Cysts after Desiccation for More than 20 YearsJournal of Clinical Microbiology, 2008
- Heparan Sulfate Proteoglycans Provide a Signal to Plasmodium Sporozoites to Stop Migrating and Productively Invade Host CellsCell Host & Microbe, 2007
- The immunology of parasite infections in immunocompromised hostsParasite Immunology, 2006